c-Src-p38 mitogen-activated protein kinase signaling is required for Akt activation in response to ionizing radiation

Molecular Cancer Research

Volumn 6, Issue 12, 2008, Pages 1872-1880

  Kim, Min Jung ^a   Byun, Joo Yun ^a   Yun, Chang Hwan ^a   Park, In Chul ^b   Lee, Kee Ho ^b   Lee, Su Jae ^a  

^a Hanyang University   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RAC1 PROTEIN; SERINE; STRESS ACTIVATED PROTEIN KINASE; THREONINE;

ARTICLE; CANCER CELL; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IONIZING RADIATION; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION ATTENUATION; RADIATION EXPOSURE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION;

CELL SURVIVAL; FEMALE; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RAC1 GTP-BINDING PROTEIN; RADIATION, IONIZING; SERINE; UTERINE CERVICAL NEOPLASMS;

EID: 57749111961     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0084     Document Type: Article

References (36)

1. Wachsberger P, Burd R, Dicker AP. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin Cancer Res 2003;9:1957-71.
2. Schmidt-Ullrich RK. Molecular targets in radiation oncology. Oncogene 2003; 22:5730-3.
3. Kubota Y, Kinoshita K, Suetomi K, et al. Mcl-1 depletion in apoptosis elicited by ionizing radiation in peritoneal resident macrophages of C3H mice. J Immunol 2007;178:2923-31.
4. Wang GJ, Cai L. Induction of cell-proliferation hormesis and cell-survival adaptive response in mouse hematopoietic cells by whole-body low-dose radiation. Toxicol Sci 2000;53:369-76.
5. Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 1999;253:239-54.
6. Li B, Desai SA, MacCorkle-Chosnek RA, et al. A novel conditional Akt 'survival switch' reversibly protects cells from apoptosis. Gene Ther 2002;9: 233-44.
7. Manning BD. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 2004;167:399-403.
8. Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A 2001;98:10983-5.
9. Wu Y, Zu K, Warren MA, et al. Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells. Mol Cancer Ther 2006;5:246-52.
10. Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001;61:3986-97.
11. Li L, Ittmann MM, Ayala G, et al. The emerging role of the PI3-K-Akt pathway in prostate cancer progression. Prostate Cancer Prostatic Dis 2005;8: 108-18.
12. Zwang Y, Yarden Y. p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J 2006;25:4195-206.
13. Lin A. A five-year itch in TNF-α cytotoxicity: the time factor determines JNK action. Dev Cell 2006;10:277-8.
14. Bowen C, Birrer M, Gelmann EP. Retinoblastoma protein-mediated apoptosis after γ-irradiation. J Biol Chem 2002;277:44969-79.
15. Li T, Dai W, Lu L. Ultraviolet-induced junD activation and apoptosis in myeloblastic leukemia ML-1 cells. J Biol Chem 2002;277:32668-76.
16. Ouwens DM, Gomes de Mesquita DS, Dekker J, et al. Hyperosmotic stress activates the insulin receptor in CHO cells. Biochim Biophys Acta 2001;1540: 97-106.
17. Stadheim TA, Kucera GL. c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells. Leuk Res 2002;26:55-65.
18. Wang X, McGowan CH, Zhao M, et al. Involvement of the MKK6-38γ cascade in γ-radiation-induced cell cycle arrest. Mol Cell Biol 2000;20:4543-52.
19. Kumar P, Miller AI, Polverini PJ. p38 MAPK mediates γ-irradiation- induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. J Biol Chem 2004;279:43352-60.
20. Reinhardt HC, Aslanian AS, Lees JA, et al. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007;11:175-89.
21. Sen P, Chakraborty PK, Raha S. Activation of p38MAPK by repetitive low-grade oxidative stress leads to pro-survival effects. Biochim Biophys Acta 2007; 1773:367-74.
22. Yamashita T, Kobayashi Y, Mizoguchi T, et al. MKK6-38 MAPK signaling pathway enhances survival but not bone-resorbing activity of osteoclasts. Biochem Biophys Res Commun 2008;365:252-7.
23. Elenitoba-Johnson KS, Jenson SD, Abbott RT, et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci U S A 2003; 100:7259-64.
24. Tang J, Qi X, Mercola D, et al. Essential role of p38γ in K-Ras transformation independent of phosphorylation. J Biol Chem 2005;280: 23910-7.
25. Crossley LJ. Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl-1. J Leukoc Biol 2003;74:583-92.
26. Li F, Malik KU. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D. J Pharmacol Exp Ther 2005;312:1043-54.
27. Lieskovska J, Ling Y, Badley-Clarke J, et al. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. J Biol Chem 2006;281:25041-53.
28. Summy JM, Trevino JG, Baker CH, et al. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Pancreas 2005;31:263-74.
29. Ishizawar R, Parsons SJ. c-Src and cooperating partners in human cancer. Cancer Cell 2004;6:209-14.
30. Taniyama Y, Ushio-Fukai M, Hitomi H, et al. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol 2004;287:C494-9.
31. Horowitz JC, Lee DY, Waghray M, et al. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-β1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 2004;279:1359-67.
32. Anter E, Thomas SR, Schulz E, et al. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem 2004;279:46637-43.
33. Uddin S, Lekmine F, Sharma N, et al. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon α-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J Biol Chem 2000;275: 27634-40.
34. Turkson J, Bowman T, Adnane J, et al. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 1999;19:7519-28.
35. Kim JY, Choi JA, Kim TH, et al. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J Cell Physiol 2002;190:29-37.
36. García Arguinzonis MI, Galler AB, Walter U, et al. Increased spreading, Rac/ p21-activated kinase (PAK) activity, and compromised cell motility in cells deficient in vasodilator-stimulated phosphoprotein (VASP). J Biol Chem 2002; 277:45604-10.